Evaluation of pharmacokinetics and safety profiles between S-1 granule and S-1 capsule in patients with solid tumors

被引：0
|
作者：
Takahashi, T. [1 ]
Hironaka, S. [2 ]
Yasui, H. [2 ]
Endo, M. [3 ]
Nakamura, Y. [1 ]
Yamamoto, N. [1 ]
Boku, N. [2 ]
机构：
[1] Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan
[2] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan
[3] Shizuoka Canc Ctr, Div Endoscope, Shizuoka, Japan
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)70463-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：136 / 136
页数：1
相关论文
共 50 条
  • [1] Effect of food and a proton pump inhibitor on the pharmacokinetics of S-1 following oral administration of S-1 in patients with advanced solid tumors
    Scheulen, Max E.
    Saito, Kaku
    Hilger, Ralf A.
    Mende, Bastian
    Zergebel, Christopher
    Strumberg, Dirk
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (03) : 753 - 761
  • [2] Effect of food and a proton pump inhibitor on the pharmacokinetics of S-1 following oral administration of S-1 in patients with advanced solid tumors
    Max E. Scheulen
    Kaku Saito
    Ralf A. Hilger
    Bastian Mende
    Christopher Zergebel
    Dirk Strumberg
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 753 - 761
  • [3] The effect of food on the pharmacokinetics of S-1 after single oral administration to patients with solid tumors
    Peters, GJ
    Noordhuis, P
    van Groeningen, CJ
    Giaccone, G
    Holwerda, U
    Voorn, D
    Schrijvers, A
    Schornagel, JH
    Beijnen, JH
    Fumoleau, P
    Schellens, JHM
    CLINICAL CANCER RESEARCH, 2004, 10 (12) : 4072 - 4076
  • [4] Pharmacokinetics of S-1 in elderly Japanese patients with cancer
    Fujita, Ken-ichi
    Nakayama, Hirofumi
    Ichikawa, Wataru
    Yamamoto, Wataru
    Endo, Hisashi
    Nagashima, Fumio
    Tanaka, Ryuhei
    Miya, Toshimichi
    Sunakawa, Yu
    Yamashita, Keishi
    Mizuno, Keiko
    Ishida, Hiroo
    Araki, Kazuhiro
    Narabayashi, Masaru
    Miwa, Keisuke
    Ando, Yuichi
    Akiyama, Yuko
    Kawara, Kaori
    Hirose, Takashi
    Sasaki, Yasutsuna
    CANCER RESEARCH, 2009, 69
  • [5] Safety and Efficacy of the S-1/Temozolomide Regimen in Patients with Metastatic Neuroendocrine Tumors
    Zhao, Jiuda
    Zhao, Hong
    Chi, Yihebali
    NEUROENDOCRINOLOGY, 2018, 106 (04) : 318 - 323
  • [6] Clinical evaluation of S-1
    Taguchi, T
    XXX WORLD CONGRESS OF THE INTERNATIONAL COLLEGE OF SURGEONS, VOLS 1-2, 1996, : 131 - 134
  • [7] Phase I study with pharmacokinetics of S-1 on an oral daily schedule for 28 days in patients with solid tumors
    Hoff, PM
    Saad, ED
    Ajani, JA
    Lassere, Y
    Wenske, C
    Medgyesy, D
    Dwivedy, S
    Russo, M
    Pazdur, R
    CLINICAL CANCER RESEARCH, 2003, 9 (01) : 134 - 142
  • [8] Comparison of the pharmacokinetics and pharmacodynamics of S-1 between Caucasian and East Asian patients
    Chuah, Benjamin
    Goh, Boon-Cher
    Lee, Soo-Chin
    Soong, Richie
    Lau, Fayce
    Mulay, Marilyn
    Dinolfo, Melissa
    Lim, Siew-Eng
    Soo, Ross
    Furuie, Taro
    Saito, Kaku
    Zergebel, Christopher
    Rosen, Lee S.
    CANCER SCIENCE, 2011, 102 (02) : 478 - 483
  • [9] Post-marketing Safety Evaluation of S-1 in Patients with Inoperable or Recurrent Breast Cancer: Especially in Patients Treated with S-1 plus Trastuzumab
    Saito, Yuki
    Oshitanai, Risa
    Terao, Mayako
    Terada, Mizuho
    Tsuda, Banri
    Okamura, Takuho
    Suzuki, Yasuhiro
    Tokuda, Yutaka
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (09) : 1051 - 1058
  • [10] Pharmacokinetics of S-1 in patients with peritoneal dissemination of gastric cancer
    Oshima, Takashi
    Yamada, Roppei
    Hatori, Shinsuke
    Kunisaki, Chikara
    Imada, Toshio
    ONCOLOGY REPORTS, 2006, 16 (02) : 361 - 366
12345